Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.
New discoveries by Jason MacGurn and colleagues further understanding of the complex machinery that cells use take up substances from outside the cell.
Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD.
Ruth Lehmann, PhD, center, a world-renowned expert on the biology of germ cells, delivered last week’s Flexner Discovery Lecture.
A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.
Molly Adele Brown, accompanied on guitar by Tim Angsten, sang at the Second Annual Southern LGBTQ Health Symposium to engage providers, students and community members throughout the region on ways to better serve sexual and gender minority patients and families.